334 related articles for article (PubMed ID: 28797122)
1. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
2. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
4. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of Prion and Abnormal Prion Protein Induces Hyperphosphorylation of α-Synuclein in the Brain Tissues from Prion Diseases and in the Cultured Cells.
Chen DD; Gao LP; Wu YZ; Chen J; Hu C; Xiao K; Chen C; Shi Q; Dong XP
ACS Chem Neurosci; 2021 Oct; 12(20):3838-3854. PubMed ID: 34595918
[TBL] [Abstract][Full Text] [Related]
6. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.
Kovacs GG; Makarava N; Savtchenko R; Baskakov IV
Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784
[TBL] [Abstract][Full Text] [Related]
7. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
8. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
9. Autocatalytic self-propagation of misfolded prion protein.
Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
[TBL] [Abstract][Full Text] [Related]
10. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
11. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.
Kim JI; Cali I; Surewicz K; Kong Q; Raymond GJ; Atarashi R; Race B; Qing L; Gambetti P; Caughey B; Surewicz WK
J Biol Chem; 2010 May; 285(19):14083-7. PubMed ID: 20304915
[TBL] [Abstract][Full Text] [Related]
12. Prion replication environment defines the fate of prion strain adaptation.
Katorcha E; Gonzalez-Montalban N; Makarava N; Kovacs GG; Baskakov IV
PLoS Pathog; 2018 Jun; 14(6):e1007093. PubMed ID: 29928047
[TBL] [Abstract][Full Text] [Related]
13. Expanding spectrum of prion diseases.
Ayers JI; Paras NA; Prusiner SB
Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
Piccardo P; King D; Telling G; Manson JC; Barron RM
J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
[TBL] [Abstract][Full Text] [Related]
15. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
17. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
18. Cell-free amplification of prions: Where do we stand?
Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
[TBL] [Abstract][Full Text] [Related]
19. Application of yeast to studying amyloid and prion diseases.
Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
[TBL] [Abstract][Full Text] [Related]
20. Recombinant prion protein induces a new transmissible prion disease in wild-type animals.
Makarava N; Kovacs GG; Bocharova O; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
Acta Neuropathol; 2010 Feb; 119(2):177-87. PubMed ID: 20052481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
